Valores de hemoglobina glucosilada en pacientes con pie diabético infectado
Contenido principal del artículo
Resumen
La diabetes mellitus tipo 2 y sus compli- caciones son padecimientos encontrados frecuentemente en el Hospital Central Militar. Dichas complicaciones son resultado del descontrol metabólico crónico, el cual pue- de ser estimado mediante la medición de hemoglobina glu- cosilada A1cl en la sangre de estos pacientes. En un estu- dio prospectivo realizado en 36 pacientes, 18 hombres y 18 mujeres, se observó que el 94.4% de ellos tenía cifras de hemoglobina glucosilada A1c por arriba del límite re- comendado para la prevención de complicaciones de 8%; sin embargo, no existe relación entre dichos valores y otros parámetros clínicos de importancia como la elevación de la glucosa plasmática o con el tiempo de evolución de la diabetes mellitus tipo 2.
Detalles del artículo
Sección
Cómo citar
Referencias
Abraira CA, Colwell JA, Nuttali FQ, Nagel NJ, Comstock JP. Vete- rans affairs cooperative study on glycemic control and complications in type II diabetes (VACSDM) 1995; 18: 1113-1123.
American Diabetes Association. Position Statement: tesis of glyce- mia in diabetes. Diabetes Care 1999; 22: 77-84.
Apelquivst J, Larsson J, Ardagh CD. Long term prognosis for dia- betic patients with foot ulcers. J Intern Med. 1993; 213: 485-491.
Bridges RM Jr, Deitch EA. Diabetic foot infections. Pathophysiolo- gy and treatment. Surg Clin North Am. 1994; 74: 537-555.
Bunn F. Evaluation of glycosilated hemoglobin in diabetic patients. Diabetes 1981; 30: 613-616.
Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabe- tes. N Eng J Med 1994; 331: 854-860.
DeFronzo RA, Reasner C. The diabetes control and complications trial study: implications for the diabetic foot. J Foot Ankle Surg 1994;331: 854-860.
Eneroth W, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997; 18: 716-722.
Gastar B, Hirsch IB. The effects of improved glycemic control and complications in type 2 diabetes. Arch Intern Med 1998; 158: 134-140.
Gavin JR, Davidson MB, DeFronzo RA, Drash A, Gabbe SG. Re- port of the expert committee on the diagnosis and classification of diabe- tes mellitus. Diabetes Care 1997; 20: 1183-1197.
Goldstein DE. Is glycosilated hemoglobin clinically usefull? N Eng J Med 1984; 9: 384-385.
Grayson ML, Diabetic foot infections. Antimicrobial therapy. In- fect Dis Clin North Am 1995; 9: 143-145.
Greenspan ES, Baxter JO. Endocrinología básica y clínica. De El Manual Moderno 1997: 671-680.
Kapplan NM. Two dilemmas of diabetes. Arch Intern Med 1991; 151: 1270-1272.
Kennedy J, Marimee J. Glycosilated serum protein and hemoglo- bin A1 levels to measure control of glycernia. Ann Int Med 1981; 51: 56-58.
Kenny SJ, Aubert RC, Geiss LS. Prevalence and incidence of non- insulin dependent diabetes. In Diabetes in America, 2nd edition. National Institutes of Health 1995: 47.
Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of gly- cated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 1998; 21: 261-269.
Klein R. Hyperglycemia and microvascular and macrovascular di- sease in diabetes. Diabetes Care 1995; 18: 258-268.
Levin JE. Preventing amputation in the patient with diabetes. Dia- betes Care 1995; 10: 1383-1392.
Lipsky BA, Pecoraro RE, Larson SA. Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch In- tern Med 1990; 150: 790-797.
Mancini L, Ruotolo V. Infection of the diabetic foot. Rays 1997; 22: 544-549.
McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 1995; 18: 216-219.
Meigs JB, Nathan DM, Cupples A, Eilson PW, Singer DE. Trac- king of glycated hemoglobin in the original cohort of the Framingham heart study. J Clin Epidemiol 1996; 49: 411-417.
Ohkubo Y, Kishikawa H, Araki E. Intensive insulin therapy pre- vents the progression of diabetic microvascular complications in japanese patients with non-insulin dependent diabetes mellitus: a randomized pros- pective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13: 513-521.
Peters AL, Davidosn MB, Schriger DL, Hasselbad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glyco- silated hemoglobin levels. JAMA 1996; 276: 1246-1252.
Rabhar S. An abnormal hemoglobin in red cells of diabetes. Clin Chem Act 1968; 22: 296-298.
Slovenkai MP. Foot problems in diabetes. Med Clin North Am 1998; 82: 940-971.
The diabetes control and complications trial research group. The effect of intensive treatment of diabetes in the development and progres- sion of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977-986.